Anhui, China

Wenliang Wang



Average Co-Inventor Count = 11.8

ph-index = 1


Company Filing History:


Years Active: 2023-2025

Loading Chart...
Loading Chart...
3 patents (USPTO):Explore Patents

Title: The Innovative Contributions of Inventor Wenliang Wang

Introduction

Wenliang Wang is an accomplished inventor based in Anhui, China, renowned for his contributions to the field of kinase inhibitors. With a total of three patents to his name, he has made significant strides in the pharmaceutical sector, focusing on therapeutic compounds that have the potential to treat complex diseases related to various kinases.

Latest Patents

Wenliang Wang's latest patents include:

1. **MST1 Kinase Inhibitor and Use Thereof** - This patent discloses a kinase inhibitor comprising a specific compound and its derivatives. It details a pharmaceutical composition that utilizes the kinase inhibitor to inhibit the activity of tyrosine kinases selected from MST1 and its mutants. The invention aims to provide new methods for preventing or treating diseases associated with MST1.

2. **Indazole Kinase Inhibitor and Use Thereof** - This patent describes a kinase inhibitor compound and its pharmaceutical formulations. It outlines methods for inhibiting crucial kinase activities associated with conditions involving mutant forms of cKIT, FLT3, PDGFRα, PDGFRβ, and VEGFR2. This innovation seeks to address disorders related to these kinases effectively.

Career Highlights

Wenliang Wang has worked with reputable organizations, including Therapeutics Science Inc. and the Chinese Academy of Sciences. His experience in these institutions has significantly contributed to his expertise in developing innovative therapeutic solutions.

Collaborations

Throughout his career, Wenliang Wang has collaborated with esteemed colleagues, such as Qingsong Liu and Jing Liu. Their joint efforts have facilitated research advancements and numerous breakthroughs in the field of kinase inhibitor technology.

Conclusion

Wenliang Wang continues to be an influential figure in the realm of pharmaceutical innovations, specifically in kinase inhibitors. His patents reflect a dedication to advancing medical science and offer promising avenues for treating diseases associated with critical kinases. As research progresses, Wang's contributions are likely to have a lasting impact on the industry and improve patient outcomes.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…